Consequently, prospective studies should investigate the temporal progression of these markers during distinct phases of pregnancy to ascertain whether CHOP and IRE‐1 alterations transpire at subsequent stages of GDM progression. This evidence concerns the gene DDIT3 and gestational diabetes.